DGKH-mediated phosphatidic acid oncometabolism as a driver of self-renewal and therapy resistance in HCC. Loh JJ, Ng KY, Huang IB, Deng M, et al. Hepatology 2025;82:308-325.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Loh JJ, Ng KY, Huang IB, Deng M, et al. DGKH-mediated phosphatidic acid oncometabolism as a driver of self-renewal and therapy resistance in HCC. Hepatology 2025;82:308-325.
PMID: 39663958